Hemophilia treatments available in Kuwait: Dr Mulla
Awareness day for hemophilia patients held
KUWAIT CITY, April 24: Director of the National Bank of Kuwait Specialized Hospital for Children, and Consultant in Pediatric, Hematology and Cancer treatments Dr. Ali Mulla Ali says the rate of patients suffering from hemophilia in the Gulf region including Kuwait is less than half of the rate in Europe, reports Aljarida daily.
In his speech given during the awareness day for hemophilia patients recently, organized in the Avenues Mall, Dr. Mulla revealed that hemophilia is a genetic disease that affects children in general, and increases blood flow due to which patients need continuous treatment.
He highlighted the availability of hemophilia treatments in Kuwait, affirming that the Ministry of Health spares no effort in providing the latest treatments, including long-term intravenous treatments.
Dr. Mulla revealed that there is a new treatment that is administered under the skin, and it is very easy for patients, especially children, as it can be taken at home and the patient does not need to go to the hospital to get that treatment.
He stressed that the awareness day for hemophilia patients came in appreciation of the patients, adding that the public were invited to the event to learn more about this disease, as there were doctors, nurses, dentists, and physiotherapists present to answer the inquiries of patients and the public.
Meanwhile, the official spokesman of the Ministry of Health Dr. Abdullah Al-Sanad said there are joint official and societal efforts to reduce and deal with hemophilia through specialized technical committees.
He explained that World Hemophilia Day is celebrated on April 17 every year. Since 1989, in coordination with the World Hemophilia Federation, this day has been dedicated to raise awareness about the disease. This day aims to shed light on the continuous progress in treatment methods since 1937 when the cause of the disease was discovered, which is the deficiency of factor VIII and IX blood clotting.
A hemophilia patient can live a normal life if necessary care is provided to him, and if his family members have full awareness about the nature of the disease, its characteristics and the expected complications, and if he is also aware of what he must do to avoid this.
Dr. Al-Sanad affirmed the importance of the role of the patient’s family, school and society in general in the patient’s coexistence with his illness without the occurrence of serious complications that could lead to disability or inability to work.
He said it is possible to limit the spread of the disease, and it is possible to avoid passing on the disease by, for example, conducting premarital tests.